annual CFF:
-$5.21B+$12.01B(+69.74%)Summary
- As of today (May 29, 2025), ABBV annual cash flow from financing activities is -$5.21 billion, with the most recent change of +$12.01 billion (+69.74%) on December 31, 2024.
- During the last 3 years, ABBV annual CFF has risen by +$13.83 billion (+72.63%).
- ABBV annual CFF is now -127.85% below its all-time high of $18.71 billion, reached on December 31, 2019.
Performance
ABBV Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$1.26B+$5.60B(+81.66%)Summary
- As of today (May 29, 2025), ABBV quarterly cash flow from financing activities is -$1.26 billion, with the most recent change of +$5.60 billion (+81.66%) on March 1, 2025.
- Over the past year, ABBV quarterly CFF has dropped by -$12.08 billion (-111.63%).
- ABBV quarterly CFF is now -104.73% below its all-time high of $26.60 billion, reached on December 31, 2019.
Performance
ABBV quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$17.29B-$12.08B(-231.76%)Summary
- As of today (May 29, 2025), ABBV TTM cash flow from financing activities is -$17.29 billion, with the most recent change of -$12.08 billion (-231.76%) on March 1, 2025.
- Over the past year, ABBV TTM CFF has dropped by -$17.08 billion (-8093.36%).
- ABBV TTM CFF is now -179.78% below its all-time high of $21.67 billion, reached on March 31, 2020.
Performance
ABBV TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ABBV Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +69.7% | -111.6% | -8093.4% |
| 3 y3 years | +72.6% | +82.0% | +24.3% |
| 5 y5 years | -127.8% | +48.1% | -179.8% |
ABBV Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +79.0% | -111.6% | +86.9% | -8093.4% | +31.6% |
| 5 y | 5-year | -127.8% | +79.0% | -111.6% | +86.9% | -179.8% | +31.6% |
| alltime | all time | -127.8% | +79.0% | -104.7% | +86.9% | -179.8% | +31.6% |
ABBV Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$1.26B(-81.7%) | -$17.29B(+231.8%) |
| Dec 2024 | -$5.21B(-69.7%) | -$6.86B(+123.3%) | -$5.21B(+86.2%) |
| Sep 2024 | - | -$3.07B(-49.6%) | -$2.80B(+17.2%) |
| Jun 2024 | - | -$6.10B(-156.4%) | -$2.39B(+1031.8%) |
| Mar 2024 | - | $10.82B(-343.2%) | -$211.00M(-98.8%) |
| Dec 2023 | -$17.22B(-30.6%) | -$4.45B(+67.2%) | -$17.22B(-23.1%) |
| Sep 2023 | - | -$2.66B(-32.1%) | -$22.41B(-11.3%) |
| Jun 2023 | - | -$3.92B(-36.7%) | -$25.26B(+5.2%) |
| Mar 2023 | - | -$6.19B(-35.7%) | -$24.02B(-3.1%) |
| Dec 2022 | -$24.80B(+30.3%) | -$9.63B(+74.6%) | -$24.80B(+15.3%) |
| Sep 2022 | - | -$5.52B(+106.0%) | -$21.51B(+9.6%) |
| Jun 2022 | - | -$2.68B(-61.6%) | -$19.63B(-14.0%) |
| Mar 2022 | - | -$6.97B(+10.0%) | -$22.84B(+19.9%) |
| Dec 2021 | -$19.04B(+65.5%) | -$6.34B(+74.0%) | -$19.04B(+16.1%) |
| Sep 2021 | - | -$3.64B(-38.1%) | -$16.40B(+5.3%) |
| Jun 2021 | - | -$5.88B(+85.4%) | -$15.57B(+27.0%) |
| Mar 2021 | - | -$3.17B(-14.1%) | -$12.25B(+6.5%) |
| Dec 2020 | -$11.50B(-161.5%) | -$3.69B(+31.3%) | -$11.50B(-161.2%) |
| Sep 2020 | - | -$2.81B(+9.5%) | $18.80B(-11.2%) |
| Jun 2020 | - | -$2.57B(+6.1%) | $21.17B(-2.3%) |
| Mar 2020 | - | -$2.42B(-109.1%) | $21.67B(+15.8%) |
| Dec 2019 | $18.71B(-230.0%) | $26.60B(-6132.2%) | $18.71B(-259.6%) |
| Sep 2019 | - | -$441.00M(-78.7%) | -$11.72B(+13.1%) |
| Jun 2019 | - | -$2.07B(-61.5%) | -$10.36B(-40.0%) |
| Mar 2019 | - | -$5.38B(+40.7%) | -$17.27B(+20.0%) |
| Dec 2018 | -$14.40B(+161.2%) | -$3.83B(-517.6%) | -$14.40B(+15.2%) |
| Sep 2018 | - | $916.00M(-110.2%) | -$12.50B(-12.1%) |
| Jun 2018 | - | -$8.98B(+257.8%) | -$14.22B(+128.4%) |
| Mar 2018 | - | -$2.51B(+30.1%) | -$6.23B(+13.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$5.51B(+40.3%) | -$1.93B(+138.0%) | -$5.51B(-9.4%) |
| Sep 2017 | - | -$810.00M(-17.3%) | -$6.09B(-8.4%) |
| Jun 2017 | - | -$980.00M(-45.4%) | -$6.65B(+47.6%) |
| Mar 2017 | - | -$1.79B(-28.3%) | -$4.50B(+14.6%) |
| Dec 2016 | -$3.93B(-168.3%) | -$2.50B(+82.5%) | -$3.93B(+1.8%) |
| Sep 2016 | - | -$1.37B(-217.8%) | -$3.86B(+8.9%) |
| Jun 2016 | - | $1.16B(-195.5%) | -$3.54B(-164.8%) |
| Mar 2016 | - | -$1.22B(-49.9%) | $5.46B(-5.0%) |
| Dec 2015 | $5.75B(-274.7%) | -$2.43B(+130.2%) | $5.75B(-21.2%) |
| Sep 2015 | - | -$1.06B(-110.4%) | $7.30B(-4.4%) |
| Jun 2015 | - | $10.17B(-1193.4%) | $7.64B(-359.3%) |
| Mar 2015 | - | -$930.00M(+5.4%) | -$2.95B(-10.5%) |
| Dec 2014 | -$3.29B(-4.3%) | -$882.00M(+22.7%) | -$3.29B(+4.3%) |
| Sep 2014 | - | -$719.00M(+73.3%) | -$3.16B(+3.5%) |
| Jun 2014 | - | -$415.00M(-67.5%) | -$3.05B(-2.7%) |
| Mar 2014 | - | -$1.28B(+71.0%) | -$3.14B(-8.9%) |
| Dec 2013 | -$3.44B(-278.2%) | -$747.00M(+21.9%) | -$3.44B(+1024.8%) |
| Sep 2013 | - | -$613.00M(+22.6%) | -$306.00M(-112.0%) |
| Jun 2013 | - | -$500.00M(-68.4%) | $2.55B(+47.9%) |
| Mar 2013 | - | -$1.58B(-166.2%) | $1.73B(-10.7%) |
| Dec 2012 | $1.93B(-128.5%) | $2.39B(+6.5%) | $1.93B(-195.6%) |
| Sep 2012 | - | $2.24B(-269.2%) | -$2.02B(-69.0%) |
| Jun 2012 | - | -$1.33B(-3.6%) | -$6.51B(-6.4%) |
| Mar 2012 | - | -$1.38B(-11.9%) | -$6.96B(+2.6%) |
| Dec 2011 | -$6.78B(<-9900.0%) | -$1.56B(-30.7%) | -$6.78B(+29.9%) |
| Sep 2011 | - | -$2.25B(+26.9%) | -$5.22B(+75.8%) |
| Jun 2011 | - | -$1.77B(+48.3%) | -$2.97B(+148.3%) |
| Mar 2011 | - | -$1.20B | -$1.20B |
| Dec 2010 | $65.00M(-101.3%) | - | - |
| Dec 2009 | -$4.88B | - | - |
FAQ
- What is AbbVie annual cash flow from financing activities?
- What is the all time high annual CFF for AbbVie?
- What is AbbVie annual CFF year-on-year change?
- What is AbbVie quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for AbbVie?
- What is AbbVie quarterly CFF year-on-year change?
- What is AbbVie TTM cash flow from financing activities?
- What is the all time high TTM CFF for AbbVie?
- What is AbbVie TTM CFF year-on-year change?
What is AbbVie annual cash flow from financing activities?
The current annual CFF of ABBV is -$5.21B
What is the all time high annual CFF for AbbVie?
AbbVie all-time high annual cash flow from financing activities is $18.71B
What is AbbVie annual CFF year-on-year change?
Over the past year, ABBV annual cash flow from financing activities has changed by +$12.01B (+69.74%)
What is AbbVie quarterly cash flow from financing activities?
The current quarterly CFF of ABBV is -$1.26B
What is the all time high quarterly CFF for AbbVie?
AbbVie all-time high quarterly cash flow from financing activities is $26.60B
What is AbbVie quarterly CFF year-on-year change?
Over the past year, ABBV quarterly cash flow from financing activities has changed by -$12.08B (-111.63%)
What is AbbVie TTM cash flow from financing activities?
The current TTM CFF of ABBV is -$17.29B
What is the all time high TTM CFF for AbbVie?
AbbVie all-time high TTM cash flow from financing activities is $21.67B
What is AbbVie TTM CFF year-on-year change?
Over the past year, ABBV TTM cash flow from financing activities has changed by -$17.08B (-8093.36%)